When Alice studied business and sustainable development at Uppsala University, she started thinking about why the most commonly used diagnostic test was single-use only. It turned out that her co-founder Robert Porter, which she met through mutual contacts, was asking the same question. Together they started the business in 2020 and has since been working on turning this idea into reality, under Alice's leadership.

Robert holds a PhD in chemistry and has many years of experience in developing and commercializing immunoassay technologies. Moreover, he helped develop the lateral-flow based pregnancy test and has founded 6 different companies within the diagnostics industry. To the company, Robert contributes with technological expertise, regulatory knowledge and an innovative mindset.

Radvile has a bachelor’s degree in chemistry from Vilnius University and a master’s degree in biomedical surface science from Malmö University. After completing her degree, she worked closely with prof. Börje Sellergren for 4 years around developing of SARs, before making the switch from academia to filling the role as the CSO of Pharmista. A transition the team is very happy about!

Annette has an executive management education from Executive Foundation Lund, a PhD in Medicine from Lund University as well as a Master's degree in Medical Biology from Linköping University. She has over 10 years of experience from project management and business development positions in privately held, listed biotech companies and the healthcare sector and is since 2017 CEO of the women’s health company Gedea Biotech

Erik is an experienced consultant within sexual and reproductive health with a specific focus on the OTC market. During his long career in women's health, he has had managerial roles at both Unipath and Alere and just recently stepped down as the CEO of Concepta Ltd. Erik is currently serving as the CEO of Lepzi which is a clinical diagnostics company.

Professor Sellergren has 20+ years of experience in the research area of interest and is one of the leading authorities in developing Synthetic Affinity Reagents (SARs) for various indications. Currently, he is serving as a professor in Biomedical Sciences at Malmö University.

Ewa recently completed her master's degree in Chemistry from the University of Warsaw, where she specialized in Radiogenomics. She has worked with many different electrochemical techniques, where she most recently helped develop a voltammetric sensor for detection and determination of various types of microplastic.

Odd has worked with business development in various industries, and has a deep understanding of the importance of human relations in developing successful businesses. As of recent, he studied psychology at the Karolinska Institute, where he is utilizing this knowledge to support the team in various ways.